tiprankstipranks
Ensysce Biosciences (ENSC)
NASDAQ:ENSC
US Market
Holding ENSC?
Track your performance easily

Ensysce Biosciences (ENSC) Financial Statements

239 Followers

Ensysce Biosciences Financial Overview

Ensysce Biosciences's market cap is currently ―. The company's EPS TTM is $-1.817; its P/E ratio is -0.36; Ensysce Biosciences is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.23. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 3.42M$ 181.80K$ 305.72K$ 1.44M-
Gross Profit$ 3.42M$ 181.80K$ 305.72K$ 515.03K$ 435.38K
EBIT$ 661.77K$ -1.97M$ 2.42M$ -3.16M$ -2.68M
EBITDA$ 661.77K$ -1.94M$ 3.59M$ -3.16M$ -2.68M
Net Income Common Stockholders$ 661.77K$ -1.97M$ -3.12M$ -3.50M$ -2.69M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 4.15M$ 1.04M$ 3.40M$ 1.12M$ 1.46M
Total Assets$ 9.38M$ 2.80M$ 5.07M$ 2.71M$ 3.22M
Total Debt$ 387.18K$ 454.46K$ 245.97K$ 854.70K$ 353.66K
Net Debt$ -3.77M$ -588.77K$ -3.16M$ -268.91K$ -1.11M
Total Liabilities$ 2.80M$ 1.32M$ 1.65M$ 3.36M$ 2.06M
Stockholders Equity$ 6.91M$ 1.81M$ 3.75M$ -322.86K$ 1.49M
Cash Flow-
Free Cash Flow$ -1.02M$ -2.31M$ -3.41M$ -1.80M$ -2.26M
Operating Cash Flow$ -1.02M$ -2.31M$ -3.41M$ -1.80M$ -2.26M
Investing Cash Flow-----
Financing Cash Flow$ 4.13M$ -51.23K$ 5.69M$ 1.46M$ -102.45K
Currency in USD

Ensysce Biosciences Earnings and Revenue History

Ensysce Biosciences Debt to Assets

Ensysce Biosciences Cash Flow

Ensysce Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis